The case of a former GlaxoSmithKline in-house lawyer who was indicted for allegedly obstructing a federal probe into off-label marketing of a drug is beginning to look a lot like a case of Lawyer vs. Lawyer vs. Lawyer.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *